Dr. Damian Redfearn was born and educated in the United Kingdom. He graduated from the University of Leicester Medical School and specialised in Internal Medicine with subspecialty training in Cardiology at the Birmingham University teaching Hospitals. He moved to Canada in 2004 to pursue research and clinical training within the field of cardiac electrophysiology
He was recruited to Queen’s University in 2006 and was appointed Director of the Heart Rhythm Service in 2007. He has overseen the growth of the electrophysiology program at Kingston General Hospital with the addition of complex ablation and the delivery of a full spectrum of electrophysiology services and procedures to the south eastern Ontario region. The simultaneous evaluation of his research outputs on the basis of how well they translate into improving patient care and outcome offers incredible opportunity for Dr. Redfearn to expand his research footprint through partnership formation with other knowledge users. For example, his academic collaborations with other cardiac electrophysiologists through the Canadian Atrial Fibrillation Stroke Prevention Intervention Network and the Cardiac Arrhythmia Network of Canada provide his research team unprecedented opportunity to validate the clinical utility of novel computational approaches in treating cardiac arrhythmias by catheter ablation. Moreover, Dr. Redfearn's strong and material industry partnerships afford opportunity to expedite the clinical development of next generation catheter ablation systems to improve the fidelity of this intervention in the clinical management of atrial fibrillation and ventricular tachycardia.
As a clinician, Dr. Redfearn was instrumental in leading the construction of a $4.5 million state of the art Electrophysiology Laboratory at Kingston General Hospital. The impressive growth of the clinical program under his leadership helped to create one of the most sophisticated complex ablation programs in Ontario, which undoubtedly builds unique research capacity for Dr. Redfearn and his colleagues to develop and implement new approaches that improve the precision and accuracy of catheter ablation in the treatment of atrial fibrillation and ventricular tachyarrhythmia.
Finally, the interdisciplinary nature of this research program is first rate. The ability for Dr. Redfearn to operate seamlessly between the research and clinical settings enhances the training experience for his highly qualified personnel (HQP), as they too, become more aware of the pathology of cardiovascular disease, clinical relevance and potential impact that is associated with their work. The ability of Dr. Redfearn to source talent from the Department of Electrical Engineering and Computer Science diversifies the talent and skill sets that are required to tackle these highly technical problems in improving the effectiveness of catheter ablation. To learn more about the Cardiac Arrhythmia Signal Analysis Lab or explore collboration please follow the link: http://www.queensu.ca/casalab/home